1. 387368dman
2. kitcaitrn
3. matthewsmelt6
4. jeepmagick
5. jil4411
1.387368dman 02/22/2018
Receives regulatory clearance to begin Phase 1 Study of ARO-AAT for treatment of Alpha-1 Liver disease
2.jeepmagick 06/18/2018
Good reason to feel good.
3.kitcaitrn 02/09/2018
Misses EPS loss estimates by $0.02 and misses on revenues
4.matthewsmelt6 03/27/2018
Arrowhead Begins Dosing in Phase 1/2 Study of ARO-HBV for Treatment of Chronic Hepatitis B
5.jeepmagick 02/15/2018
Receives regulatory clearance to begin Phase 1/2 study of ARO=HBV for treatment of Hepatitis B
6.387368dman 05/21/2018
Presents new data on ARO-ENaC
7.kitcaitrn 02/15/2018
Granted orphan drug designation
8.387368dman 02/12/2018
Cantor Fitzgerald raises price target to $5 from $2
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW